These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12629207)

  • 1. The topoisomerase IIbeta circular clamp arrests transcription and signals a 26S proteasome pathway.
    Xiao H; Mao Y; Desai SD; Zhou N; Ting CY; Hwang J; Liu LF
    Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3239-44. PubMed ID: 12629207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 26 S proteasome-mediated degradation of topoisomerase II cleavable complexes.
    Mao Y; Desai SD; Ting CY; Hwang J; Liu LF
    J Biol Chem; 2001 Nov; 276(44):40652-8. PubMed ID: 11546768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of topoisomerase II stability and activity by ubiquitination and SUMOylation: clinical implications for cancer chemotherapy.
    Ma Y; North BJ; Shu J
    Mol Biol Rep; 2021 Sep; 48(9):6589-6601. PubMed ID: 34476738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane.
    Lyu YL; Kerrigan JE; Lin CP; Azarova AM; Tsai YC; Ban Y; Liu LF
    Cancer Res; 2007 Sep; 67(18):8839-46. PubMed ID: 17875725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SUMO pathway is required for selective degradation of DNA topoisomerase IIbeta induced by a catalytic inhibitor ICRF-193(1).
    Isik S; Sano K; Tsutsui K; Seki M; Enomoto T; Saitoh H; Tsutsui K
    FEBS Lett; 2003 Jul; 546(2-3):374-8. PubMed ID: 12832072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E3 ubiquitin-ligase Bmi1/Ring1A controls the proteasomal degradation of Top2alpha cleavage complex - a potentially new drug target.
    Alchanati I; Teicher C; Cohen G; Shemesh V; Barr HM; Nakache P; Ben-Avraham D; Idelevich A; Angel I; Livnah N; Tuvia S; Reiss Y; Taglicht D; Erez O
    PLoS One; 2009 Dec; 4(12):e8104. PubMed ID: 19956605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular processing pathways contribute to the activation of etoposide-induced DNA damage responses.
    Fan JR; Peng AL; Chen HC; Lo SC; Huang TH; Li TK
    DNA Repair (Amst); 2008 Mar; 7(3):452-63. PubMed ID: 18206427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription-dependent degradation of topoisomerase I-DNA covalent complexes.
    Desai SD; Zhang H; Rodriguez-Bauman A; Yang JM; Wu X; Gounder MK; Rubin EH; Liu LF
    Mol Cell Biol; 2003 Apr; 23(7):2341-50. PubMed ID: 12640119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topoisomerase IIβ deficiency enhances camptothecin-induced apoptosis.
    Lin RK; Ho CW; Liu LF; Lyu YL
    J Biol Chem; 2013 Mar; 288(10):7182-92. PubMed ID: 23344961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressing proteasome mediated processing of topoisomerase II DNA-protein complexes preserves genome integrity.
    Sciascia N; Wu W; Zong D; Sun Y; Wong N; John S; Wangsa D; Ried T; Bunting SF; Pommier Y; Nussenzweig A
    Elife; 2020 Feb; 9():. PubMed ID: 32057297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCF
    Shu J; Cui D; Ma Y; Xiong X; Sun Y; Zhao Y
    Oncogenesis; 2020 Feb; 9(2):8. PubMed ID: 32015321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repair of trapped topoisomerase II covalent cleavage complexes: Novel proteasome-independent mechanisms.
    Tsuda M; Kitamasu K; Hosokawa S; Nakano T; Ide H
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):170-184. PubMed ID: 31608820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2 provides TOP2 poison resistance by promoting proteolysis of TOP2βcc in a p53-independent manner.
    Shu J; Jiang J; Wang X; Yang X; Zhao G; Cai T
    Cell Death Dis; 2024 Jan; 15(1):83. PubMed ID: 38263255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of a novel ubiquitin-independent proteasome pathway when RNA polymerase II encounters a protein roadblock.
    Ban Y; Ho CW; Lin RK; Lyu YL; Liu LF
    Mol Cell Biol; 2013 Oct; 33(20):4008-16. PubMed ID: 23938298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Molecule Inhibitors Confirm Ubiquitin-Dependent Removal of TOP2-DNA Covalent Complexes.
    Swan RL; Poh LLK; Cowell IG; Austin CA
    Mol Pharmacol; 2020 Sep; 98(3):222-233. PubMed ID: 32587095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acidic pH induces topoisomerase II-mediated DNA damage.
    Xiao H; Li TK; Yang JM; Liu LF
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5205-10. PubMed ID: 12692309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular determinants of response to topoisomerase II inhibitors].
    Lansiaux A; Pourquier P
    Bull Cancer; 2011 Nov; 98(11):1299-310. PubMed ID: 22023806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms to Repair Stalled Topoisomerase II-DNA Covalent Complexes.
    Swan RL; Cowell IG; Austin CA
    Mol Pharmacol; 2022 Jan; 101(1):24-32. PubMed ID: 34689119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic evidence for involvement of two distinct nonhomologous end-joining pathways in repair of topoisomerase II-mediated DNA damage.
    Adachi N; Iiizumi S; So S; Koyama H
    Biochem Biophys Res Commun; 2004 Jun; 318(4):856-61. PubMed ID: 15147950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression.
    Nip J; Hiebert SW
    Cell Biochem Biophys; 2000; 33(2):199-207. PubMed ID: 11325040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.